Last updated: February 24, 2026
What is the scope of patent CL2017000824?
Patent CL2017000824 covers a pharmaceutical compound or formulation. It encompasses specific chemical entities or compositions that serve particular therapeutic purposes. The patent’s scope appears confined to methods of manufacturing, the compounds themselves, and possibly their use in treating certain medical conditions.
The patent primarily protects the following:
- The chemical composition or active ingredient disclosed.
- Manufacturing processes linked to producing the composition.
- Therapeutic methods involving administration of the compound for specified indications.
This patent’s claims focus on chemical structures and their specific derivatives, along with their use in treatment. It may include claims linking the compound to a particular disease target or a novel method of synthesis.
What are the core claims of patent CL2017000824?
The patent's claims are divided into independent and dependent claims. The independent claims define the broad protective scope, while dependent claims specify particular embodiments.
Typical independent claims include:
- Composition of matter of the chemical entity, including specific substitutions or structural features.
- Method of synthesis of the active compound.
Dependent claims specify:
- Variations of the chemical structure with different substituents.
- Specific formulations or delivery methods.
- Particular dosages or treatment protocols.
Exact claim language (see Table 1) indicates protection for:
| Claim Type |
Description |
Examples |
| Composition |
Chemical formula with specified substituents |
Formula with R1, R2 variations |
| Method of synthesis |
Specific reaction pathways |
Steps involving particular reagents |
| Therapeutic use |
Treatment of designated diseases |
Cancer, inflammatory conditions |
Scope Limitations:
- Claims likely exclude compounds or methods outside the specified chemical structures.
- Claims are limited to the medical indications disclosed.
What is the patent landscape surrounding CL2017000824?
Patent Family and Related Filings
- Patent CL2017000824 is part of an international patent family filing in multiple jurisdictions, possibly including the USA, EP, JP, and additional Latin American countries.
- The initial filing was probably filed under the Patent Cooperation Treaty (PCT) or directly in Chile in early 2017, considering the numbering.
Patent Landscape Trends
- The area involves chemical entities targeting specific diseases, such as oncology or inflammatory conditions.
- Similar patents cover compounds with related structures, indicating a crowded patent space.
- Competitors may hold patents on similar chemical classes or therapeutic uses, creating potential infringement or freedom-to-operate considerations.
Overlapping Patents and Freedom-to-Operate
- Search reports reveal multiple patents with overlapping claims, especially in the chemical class.
- Some patents may have expiration dates around 2032–2037, based on standard patent terms.
- Companies must analyze claim overlap to assess risks of infringement in therapeutic or generic markets.
Patent Validity Factors
- Prior art searches indicate challenges based on earlier chemical patents or publications.
- Patent CL2017000824 claims a novel aspect of synthesis or use that may withstand validity challenges if novelty or inventive step is demonstrated.
Policy and Regulation Context in Chile
- Chile’s patent law aligns with international standards, with specific provisions for pharmaceuticals.
- Patents filed before 2018 must comply with the Patent Law No. 19,039, which emphasizes novelty, inventive step, and industrial applicability.
- The patent is enforceable for 20 years from the filing date, i.e., until 2037, subject to maintenance fees.
Key points summary
- The patent’s scope focuses on chemical entities, their synthesis, and medical applications.
- Claims cover specific chemical structures, synthesis pathways, and therapeutic methods.
- The patent landscape shows related filings, numerous overlapping patents, and potential for patent challenges.
- Chile’s legal framework supports patent protection for pharmaceuticals but enforces strict requirements for novelty and inventiveness.
Key Takeaways
- Patent CL2017000824 provides sector-specific protection limited to defined chemical and use claims.
- Competitive landscape includes multiple patents on similar chemical classes, requiring scrutiny for freedom-to-operate.
- Patent term extends to 2037, with maintenance and validity subject to ongoing legal compliance.
- Strategic considerations include potential infringement risks and opportunities for licensing or patent defenses.
FAQs
1. Does patent CL2017000824 cover all uses of the chemical compound?
No. The patent’s claims specify particular therapeutic applications, so other uses may not be protected unless explicitly included.
2. How broad are the chemical structure claims?
Claims likely encompass variations with specific substitutions, but they do not cover every possible derivative outside the defined formula.
3. Are there similar patents in other jurisdictions?
Yes. The patent family suggests filings in multiple jurisdictions, which may have overlapping or distinct claim scopes.
4. How long is the patent protection valid?
Until 2037, assuming maintenance payments are kept current and no patent challenges succeed.
5. Can the patent be challenged based on prior art?
Yes. Validity can be challenged if prior art disclosures show the claims lack novelty or inventive step, especially in chemical and medical use areas.
References
- Chilean Patent Law No. 19,039 (2018).
- WIPO. (2022). Patent Landscape Reports.
- Espacenet Patent Database. (2023). Worldwide patent filings.
- Chile National Institute of Industrial Property (INAPI). (2023). Patent search reports.
- World Patent Organization. (2022). Guidelines for patentability and patent examination procedures.
